Drug manufacturers help anti-doping officers to develop detection tests

Nowadays a lot of pharmaceutical companies are ready to cooperate with anti-doping officials in their fight against administration of banned drugs in sports. It sounds strange but this is the reality. In fact, if you review the fate of EPO, you can comprehend why drug manufacturers agree to support efforts of anti-doping agencies. EPO is actually an effective remedy for treatment of anemia. Numerous individuals with anemia that have used EPO have been treated. But what do you think while hearing about this medication? Almost any individual associates this remedy just with doping in sports. This preparation has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. Thus, EPO is associated only with lying, dishonor, etc. Looking at this situation, pharmaceutical companies try to “defend” their medicines from the similar fate. That’s why they cooperate with anti-doping agencies.
However certain pharmaceutical companies began to cooperate with anti-doping agencies long ago, sometimes there were certain problems between them. Anti-doping officers criticized some pharmaceutical companies for their connections with doping.
Nowadays relations between anti-doping officials and pharmaceutical companies are better. Pharmaceutical companies share detailed information about new drugs with anti-doping officers. It is precious information for development of detection tests for these drugs. While anti-doping agencies find out how medications are manufactured, how they pass into body, how they work in the body, they can introduce more efficacious tests for these preparations.
For example, the company Roche that introduced the medicine CERA helped anti-doping officers to develop a detection test for it. Later other companies followed the example of Roche. The pharmaceutical company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during the 2012 Olympics.
While relations between anti-doping officers and big drug manufacturers become stronger, smaller pharmaceutical companies started to cooperate with anti-doping officers as well. While previously pharmaceutical companies haven’t desired to discuss about their relations with anti-doping officers openly, now they don’t fear to announce about this condition.